Literature DB >> 8583852

Expression of growth factors, proto-oncogenes, and p53 in nasopharyngeal angiofibromas.

M A Nagai1, O Butugan, A Logullo, M M Brentani.   

Abstract

Biopsies from 25 juvenile nasopharyngeal angiofibromas (JNAs) and respective normal inferior turbinates were examined and compared. The expression patterns of the messenger RNAs (mRNAs) for various growth factors possibly involved in the growth of mesenchymal cells, as well as angiogenesis and fibrosis, were also compared. These growth factors included insulin-like growth factor II (IGF-II), basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), transforming growth factors-beta1 (TGF-beta1) and platelet-derived growth factors (PDGF-A and PDGF-B). Quantification of mRNA coding for proto-oncogenes and suppressor genes related to proliferation (i.e., c-myc, c-fos, p53) was also undertaken. Tumor and turbinates expressed similar levels of bFGF, VEGF, TGF-beta1, c-myc, c-fos, and PDGF-A mRNAs. The presence of TGF-beta1 protein was confirmed by immunohistochemistry in several structures that characterize the lesions of JNA, which suggests that TGF-beta1 may play a role in the development of the fibrous component of this tumor. PDGF-B and p53 were overexpressed (i.e., twice the mean level found in turbinates) in 50% and 32% of JNAs, respectively but there was no statistical significance when compared with controls. Statistically significant increased expression of IGF-II mRNA was observed in JNA (P = .04). IGF-II mRNA levels were correlated to p53 (P = .05) and PDGF-B (P = .034), indicating a possible synergistic action of such factors in JNA. The results of this study suggest that IGF-II might be a potential growth regulator of nasopharyngeal angiofibromas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8583852     DOI: 10.1097/00005537-199602000-00016

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma.

Authors:  Zhaojian Gong; Qian Yang; Zhaoyang Zeng; Wenling Zhang; Xiayu Li; Xuyu Zu; Hao Deng; Pan Chen; Qianjin Liao; Bo Xiang; Ming Zhou; Xiaoling Li; Yong Li; Wei Xiong; Guiyuan Li
Journal:  Tumour Biol       Date:  2015-10-13

2.  Immunohistochemical analysis of growth mechanisms in juvenile nasopharyngeal angiofibroma.

Authors:  Robert Schuon; Jürgen Brieger; Ulf R Heinrich; Yeduha Roth; Witold Szyfter; Wolf J Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-12-20       Impact factor: 2.503

3.  Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma--do they have a role?

Authors:  Suvi Renkonen; Valtteri Häyry; Päivi Heikkilä; Ilmo Leivo; Caj Haglund; Antti A Mäkitie; Jaana Hagström
Journal:  Virchows Arch       Date:  2010-11-27       Impact factor: 4.064

4.  Clinical correlation of molecular (VEGF, FGF, PDGF, c-Myc, c-Kit, Ras, p53) expression in juvenile nasopharyngeal angiofibroma.

Authors:  Anupam Mishra; Subhash Chandra Mishra; Ashoak Mani Tripathi; Amita Pandey
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-08-31       Impact factor: 2.503

5.  The changing surgical management of juvenile nasopharyngeal angiofibroma.

Authors:  Suvi Renkonen; Jaana Hagström; Jyrki Vuola; Mika Niemelä; Matti Porras; Sanna-Maria Kivivuori; Ilmo Leivo; Antti A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-17       Impact factor: 2.503

6.  Juvenile nasopharyngeal angiofibroma-our experience at a referral hospital.

Authors:  Vikas Sinha; Manish Ninama; Bela Prajapati; Devang Gupta; Yogesh More; Vadisha Bhat; Shashank Nath Singh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2009-03-21

7.  Juvenile angiofibroma: evolution of management.

Authors:  Piero Nicolai; Alberto Schreiber; Andrea Bolzoni Villaret
Journal:  Int J Pediatr       Date:  2011-11-17

8.  Neural Crest Stem Cells in Juvenile Angiofibromas.

Authors:  Bernhard Schick; Lukas Pillong; Gentiana Wenzel; Silke Wemmert
Journal:  Int J Mol Sci       Date:  2022-02-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.